SLC5A4
gene geneOn this page
Also known as SAAT1SGLT3DJ90G24.4
Summary
SLC5A4 (solute carrier family 5 member 4, HGNC:11039) is a protein-coding gene on chromosome 22q12.3, encoding Probable glucose sensor protein SLC5A4 (Q9NY91). Does not function as sodium/D-glucose symporter.
Predicted to enable low-affinity D-glucose:sodium symporter activity. Predicted to be involved in D-glucose transmembrane transport and sodium ion transport. Predicted to act upstream of or within proton transmembrane transport. Predicted to be located in membrane. Predicted to be active in plasma membrane.
Source: NCBI Gene 6527 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 114 total
- MANE Select transcript:
NM_014227
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11039 |
| Approved symbol | SLC5A4 |
| Name | solute carrier family 5 member 4 |
| Location | 22q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SAAT1, SGLT3, DJ90G24.4 |
| Ensembl gene | ENSG00000100191 |
| Ensembl biotype | protein_coding |
| OMIM | 618633 |
| Entrez | 6527 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000266086
RefSeq mRNA: 1 — MANE Select: NM_014227
NM_014227
CCDS: CCDS13903
Canonical transcript exons
ENST00000266086 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000653378 | 32218464 | 32218725 |
| ENSE00000653379 | 32220920 | 32221022 |
| ENSE00000653380 | 32224267 | 32224482 |
| ENSE00000653382 | 32225655 | 32225823 |
| ENSE00000653390 | 32247411 | 32247515 |
| ENSE00000653391 | 32248743 | 32248802 |
| ENSE00000879965 | 32234873 | 32235093 |
| ENSE00000879966 | 32251770 | 32251874 |
| ENSE00000911204 | 32230968 | 32231075 |
| ENSE00000911206 | 32254142 | 32254213 |
| ENSE00000911207 | 32255195 | 32255347 |
| ENSE00001626704 | 32229194 | 32229344 |
| ENSE00001688297 | 32238985 | 32239090 |
| ENSE00001787189 | 32237244 | 32237324 |
| ENSE00001801487 | 32232899 | 32233034 |
Expression profiles
Bgee: expression breadth ubiquitous, 144 present calls, max score 77.24.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1248 / max 133.0594, expressed in 7 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 193740 | 0.1248 | 7 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| duodenum | UBERON:0002114 | 77.24 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.33 | silver quality |
| buccal mucosa cell | CL:0002336 | 76.01 | silver quality |
| endometrium epithelium | UBERON:0004811 | 73.66 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 72.12 | gold quality |
| paraflocculus | UBERON:0005351 | 69.46 | gold quality |
| frontal pole | UBERON:0002795 | 68.81 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 68.37 | gold quality |
| islet of Langerhans | UBERON:0000006 | 66.17 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 63.23 | gold quality |
| small intestine | UBERON:0002108 | 62.93 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 61.81 | gold quality |
| body of uterus | UBERON:0009853 | 61.72 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 61.22 | gold quality |
| sural nerve | UBERON:0015488 | 60.94 | silver quality |
| right lung | UBERON:0002167 | 60.76 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 60.04 | gold quality |
| upper lobe of lung | UBERON:0008948 | 59.75 | gold quality |
| thyroid gland | UBERON:0002046 | 59.68 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 59.63 | gold quality |
| endocervix | UBERON:0000458 | 57.81 | gold quality |
| ectocervix | UBERON:0012249 | 56.75 | gold quality |
| gall bladder | UBERON:0002110 | 56.73 | gold quality |
| cerebellar vermis | UBERON:0004720 | 56.67 | gold quality |
| omental fat pad | UBERON:0010414 | 56.61 | gold quality |
| peritoneum | UBERON:0002358 | 56.56 | gold quality |
| left uterine tube | UBERON:0001303 | 56.17 | gold quality |
| cortex of kidney | UBERON:0001225 | 56.16 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 55.73 | gold quality |
| pancreas | UBERON:0001264 | 55.70 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.06 |
| E-GEOD-99795 | no | 6.02 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- determination that SGLT3 is not a Na+/glucose cotransporter but instead a glucose sensor in the plasma membrane of cholinergic neurons, skeletal muscle, and other tissues (PMID:13130073)
- substrate specificity study of imino sugars with hSGLT3; results for hSGLT3 are compared with those for alpha-glucosidases and human SGLT type 1 (PMID:17110502)
- Suggest SGLT3 may be a possible candidate for changes in membrane potential of skeletal muscle during periods of glucose-supplemented exercise. (PMID:18198291)
- hSGLT3 functions as a sugar sensor in vivo and mutating a single amino acid converts this sugar sensor into a sugar transporter similar to SGLT1. (PMID:20421923)
- the expression and functional role of SGLT3 in the human kidney (PMID:22766068)
- Data suggest SGLT3 in neurons of portal vein wall plays role in sensing blood glucose level and in satiety response; dietary protein indirectly affects satiety response via up-regulation of intestinal gluconeogenesis and thus blood glucose. [REVIEW] (PMID:25200297)
- Whole-exome sequencing (WES) of several extended pedigrees with high density of attention-deficit/hyperactivity disorder (ADHD) identified a triplet ATG deletion in SLC5A4 leading to a single amino acid loss (DeltaM500) in the hSGLT3 protein imperfectly co-segregating with the clinical phenotype of ADHD. [DeltaM500] in hSGLT3 inhibits membrane targeting and thus largely disrupts glucose-induced sodium conductance. (PMID:30286162)
- Intestinal sodium/glucose cotransporter 3 expression is epithelial and downregulated in obesity. (PMID:33385407)
Cross-species orthologs
16 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc5a8l | ENSDARG00000003697 |
| mus_musculus | Slc5a4a | ENSMUSG00000020229 |
| rattus_norvegicus | Slc5a4 | ENSRNOG00000049734 |
| drosophila_melanogaster | CG2187 | FBGN0017448 |
| drosophila_melanogaster | rumpel | FBGN0029950 |
| drosophila_melanogaster | SLC5A11 | FBGN0031998 |
| drosophila_melanogaster | bumpel | FBGN0037895 |
| drosophila_melanogaster | ChT | FBGN0038641 |
| drosophila_melanogaster | salt | FBGN0039872 |
| drosophila_melanogaster | Smvt | FBGN0039873 |
| drosophila_melanogaster | CG31262 | FBGN0051262 |
| drosophila_melanogaster | CG31668 | FBGN0051668 |
| drosophila_melanogaster | CG33124 | FBGN0053124 |
| drosophila_melanogaster | kumpel | FBGN0250757 |
| caenorhabditis_elegans | WBGENE00000501 | |
| caenorhabditis_elegans | WBGENE00014092 |
Paralogs (12): SLC5A1 (ENSG00000100170), SLC5A5 (ENSG00000105641), SLC5A7 (ENSG00000115665), SLC5A9 (ENSG00000117834), SLC5A6 (ENSG00000138074), SLC5A2 (ENSG00000140675), SLC5A12 (ENSG00000148942), SLC5A10 (ENSG00000154025), SLC5A11 (ENSG00000158865), SLC5A3 (ENSG00000198743), SLC5A8 (ENSG00000256870), (ENSG00000293606)
Protein
Protein identifiers
Probable glucose sensor protein SLC5A4 — Q9NY91 (reviewed: Q9NY91)
Alternative names: Solute carrier family 5 member 4
All UniProt accessions (1): Q9NY91
UniProt curated annotations — full annotation on UniProt →
Function. Does not function as sodium/D-glucose symporter. However, may function as a D-glucose sensor by generating a D-glucose-induced depolarization which is pH-independent, Na(+)-dependent at neutral pH and probably H(+)-dependent at acidic pH.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in skeletal muscle, where it may localize to the neuromuscular junction (at protein level). Expressed in small intestine where it may localize to cholinergic neurons of the submucosal plexus and myenteric plexus (at protein level). Detected in kidney (at protein level).
Activity regulation. Inhibited by phlorizin.
Miscellaneous. Although it belongs to the sodium:solute symporter (SSF) (TC 2.A.21) family, lacks Na(+)/glucose symporter activity.
Similarity. Belongs to the sodium:solute symporter (SSF) (TC 2.A.21) family.
RefSeq proteins (1): NP_055042* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001734 | Na/solute_symporter | Family |
| IPR018212 | Na/solute_symporter_CS | Conserved_site |
| IPR038377 | Na/Glc_symporter_sf | Homologous_superfamily |
Pfam: PF00474
UniProt features (32 total): topological domain 11, transmembrane region 11, sequence conflict 3, sequence variant 2, chain 1, region of interest 1, compositionally biased region 1, glycosylation site 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NY91-F1 | 85.31 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 248
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 457 | confers sugar transport activity not found in the wild-type protein. increased sensitivity to inhibitor phlorizin. |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-189200 | Cellular hexose transport |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-425407 | SLC-mediated transmembrane transport |
MSigDB gene sets: 83 (showing top):
GOBP_CARBOHYDRATE_TRANSPORT, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, HNF1_Q6, GOBP_MONOATOMIC_CATION_TRANSPORT, HNF1_C, HNF1_01, GOBP_RENAL_ABSORPTION, GOBP_IMPORT_INTO_CELL, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, MODULE_342, GOBP_RENAL_SYSTEM_PROCESS, MODULE_69, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
GO Biological Process (4): sodium ion transport (GO:0006814), monoatomic ion transport (GO:0006811), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085)
GO Molecular Function (3): solute:sodium symporter activity (GO:0015370), protein binding (GO:0005515), transmembrane transporter activity (GO:0022857)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| SLC-mediated transmembrane transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 2 |
| metal ion transport | 1 |
| sodium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| cellular process | 1 |
| sodium ion transmembrane transporter activity | 1 |
| solute:monoatomic cation symporter activity | 1 |
| binding | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
955 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC5A4 | Q92681 | Q92681 | 924 |
| SLC5A4 | SLC2A2 | P11168 | 628 |
| SLC5A4 | TAS1R2 | Q8TE23 | 606 |
| SLC5A4 | TAS1R3 | Q7RTX0 | 580 |
| SLC5A4 | SLC2A5 | P22732 | 538 |
| SLC5A4 | SLC2A11 | Q9BYW1 | 536 |
| SLC5A4 | SLC2A7 | Q6PXP3 | 512 |
| SLC5A4 | H7C1H1 | H7C1H1 | 511 |
| SLC5A4 | SLC2A12 | Q8TD20 | 495 |
| SLC5A4 | SLC2A8 | Q9NY64 | 490 |
| SLC5A4 | SLC2A14 | Q8TDB8 | 445 |
| SLC5A4 | SLC2A6 | Q9UGQ3 | 436 |
| SLC5A4 | SLC2A13 | Q96QE2 | 413 |
| SLC5A4 | SLC35E4 | Q6ICL7 | 382 |
| SLC5A4 | GNAT3 | A8MTJ3 | 375 |
| SLC5A4 | ALDH18A1 | P54886 | 375 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KASH5 | SLC5A4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM237 | SLC5A4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A3 | SLC5A4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLM1 | SLC5A4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OPRPN | SLC5A4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SLC5A4 | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| SLC5A4 | CLGN | psi-mi:“MI:0914”(association) | 0.350 |
| SLC5A4 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC5A4 | TMEM237 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC5A4 | MS4A3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC5A4 | GOLM1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (40): GOLM1 (Two-hybrid), MS4A3 (Two-hybrid), TMEM237 (Two-hybrid), CCDC155 (Two-hybrid), PIGM (Affinity Capture-MS), YIPF3 (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), OMA1 (Affinity Capture-MS), CERS6 (Affinity Capture-MS), FITM2 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), ERMP1 (Affinity Capture-MS), GPR89A (Affinity Capture-MS), ICAM4 (Affinity Capture-MS), FADS1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1D8PDB5, A0A1D8PNR5, A1A654, C8V329, D3ZIS0, F4KD71, F9X9V3, I1RAK8, K3UII4, L7WU90, O14035, O74248, O74537, O80592, O94469, P05316, P17064, P22152, P31636, P32837, P33413, P38090, P38196, P38724, P38731, P39980, P40039, P53099, Q04895, Q05998, Q08485, Q08579, Q09887, Q10279, Q12119, Q21434, Q42400, Q4WGE2, Q7XBS0, Q874L4
Diamond homologs: A0PJK1, A8I1B9, A8WHP3, D3ZIS0, P11170, P13866, P26429, P26430, P31636, P31637, P31639, P53790, P53791, P53792, P53793, P53794, P96169, Q28610, Q28728, Q2M3M2, Q3ZC26, Q5FY69, Q5SWY8, Q6R4Q5, Q8C3K6, Q8K0E3, Q8VDT1, Q8WWX8, Q91ZP4, Q923I7, Q9ET37, Q9JKZ2, Q9NY91, Q9Z1F2, P31448
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
114 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 95 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1853 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:32218726:C:CC | acceptor_gain | 1.0000 |
| 22:32220916:TTACC:T | donor_loss | 1.0000 |
| 22:32220919:C:A | donor_loss | 1.0000 |
| 22:32220919:CCTT:C | donor_gain | 1.0000 |
| 22:32220946:T:TA | donor_gain | 1.0000 |
| 22:32221018:TACAG:T | acceptor_gain | 1.0000 |
| 22:32221019:ACAG:A | acceptor_gain | 1.0000 |
| 22:32221020:CAG:C | acceptor_gain | 1.0000 |
| 22:32221020:CAGC:C | acceptor_gain | 1.0000 |
| 22:32221021:AG:A | acceptor_gain | 1.0000 |
| 22:32221022:GC:G | acceptor_loss | 1.0000 |
| 22:32221023:C:CC | acceptor_gain | 1.0000 |
| 22:32221023:C:T | acceptor_loss | 1.0000 |
| 22:32221028:C:CT | acceptor_gain | 1.0000 |
| 22:32221029:A:T | acceptor_gain | 1.0000 |
| 22:32221035:C:CT | acceptor_gain | 1.0000 |
| 22:32221035:C:T | acceptor_gain | 1.0000 |
| 22:32224405:C:CA | donor_gain | 1.0000 |
| 22:32225650:CTCA:C | donor_loss | 1.0000 |
| 22:32225651:TCA:T | donor_loss | 1.0000 |
| 22:32225652:CAC:C | donor_loss | 1.0000 |
| 22:32225653:A:AT | donor_loss | 1.0000 |
| 22:32225820:TATC:T | acceptor_gain | 1.0000 |
| 22:32225821:ATCC:A | acceptor_loss | 1.0000 |
| 22:32225822:TC:T | acceptor_gain | 1.0000 |
| 22:32225823:CC:C | acceptor_gain | 1.0000 |
| 22:32225823:CCTG:C | acceptor_loss | 1.0000 |
| 22:32225824:C:CC | acceptor_gain | 1.0000 |
| 22:32225825:T:A | acceptor_loss | 1.0000 |
| 22:32229190:TCA:T | donor_loss | 1.0000 |
AlphaMissense
4297 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:32225793:G:C | S437R | 0.991 |
| 22:32225793:G:T | S437R | 0.991 |
| 22:32225795:T:G | S437R | 0.991 |
| 22:32229298:G:C | S392R | 0.991 |
| 22:32229298:G:T | S392R | 0.991 |
| 22:32229300:T:G | S392R | 0.991 |
| 22:32232913:C:G | R336P | 0.990 |
| 22:32232915:G:C | S335R | 0.990 |
| 22:32232915:G:T | S335R | 0.990 |
| 22:32232917:T:G | S335R | 0.990 |
| 22:32229268:G:C | S402R | 0.988 |
| 22:32229268:G:T | S402R | 0.988 |
| 22:32229270:T:G | S402R | 0.988 |
| 22:32231015:C:G | C361S | 0.986 |
| 22:32231016:A:T | C361S | 0.986 |
| 22:32229274:G:C | S400R | 0.985 |
| 22:32229274:G:T | S400R | 0.985 |
| 22:32229276:T:G | S400R | 0.985 |
| 22:32231045:C:G | C351S | 0.980 |
| 22:32231046:A:T | C351S | 0.980 |
| 22:32234932:A:G | W276R | 0.980 |
| 22:32234932:A:T | W276R | 0.980 |
| 22:32229336:C:G | G380R | 0.978 |
| 22:32231016:A:G | C361R | 0.978 |
| 22:32232926:C:A | G332W | 0.977 |
| 22:32233021:C:G | R300P | 0.977 |
| 22:32229194:C:G | R427P | 0.976 |
| 22:32231063:C:G | C345S | 0.976 |
| 22:32231064:A:T | C345S | 0.976 |
| 22:32255248:C:G | D28H | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000001733 (22:32304417 C>T), RS1000076488 (22:32352011 T>A), RS1000081190 (22:32259597 C>T), RS1000084762 (22:32292501 T>C), RS1000098395 (22:32300262 T>C), RS1000118163 (22:32265733 G>A,C), RS1000120746 (22:32350983 C>T), RS1000150776 (22:32347171 G>A), RS1000184165 (22:32318454 G>A,T), RS1000188467 (22:32288697 C>T), RS1000201332 (22:32354326 T>A,C), RS1000248961 (22:32234411 T>G), RS1000277414 (22:32349183 C>T), RS1000288578 (22:32276022 G>A), RS1000295788 (22:32333806 C>T)
Disease associations
OMIM: gene MIM:618633 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003773_10 | Loneliness (multivariate analysis) | 2.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007865 | loneliness measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Hexose transporter family
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases expression | 3 |
| sodium arsenite | affects methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, affects response to substance, increases expression | 1 |
| abrine | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Lipopolysaccharides | increases expression, affects response to substance, affects cotreatment | 1 |
| Methapyrilene | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TN99 | HAP1 SLC5A4 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.